1.Primary Synovial Sarcoma of Lung.
Devrim CABUK ; Berna USTUNER ; Asli Gul AKGUL ; Ozgur ACIKGOZ ; Busra YAPRAK ; Kazim UYGUN ; Salih TOPCU ; Bahar MUEZZINOGLU
The Korean Journal of Thoracic and Cardiovascular Surgery 2014;47(3):306-309
Synovial sarcoma (SS) is a highly malignant tumor that accounts for 10% of all soft-tissue sarcomas. Primary SS arising from the lung is extremely rare, and the prognosis is poor. We report a case of pulmonary SS presenting with a mass lesion invading the right upper and middle lobes, extending to the mediastinum and the chest wall. After tru-cut biopsy, surgical resection was performed. The final diagnosis was SS (biphasic type) based on histological and immunohistochemical findings. There are no guidelines for optimal treatment due to the rarity of these tumors. Current treatment includes surgery and adjuvant chemotherapy and/or radiotherapy.
Biopsy
;
Chemotherapy, Adjuvant
;
Diagnosis
;
Immunohistochemistry
;
Lung*
;
Mediastinum
;
Prognosis
;
Radiotherapy
;
Sarcoma
;
Sarcoma, Synovial*
;
Thoracic Wall
2.Evaluation of prophylactic and therapeutic effects of ruscogenin on acute radiation proctitis: an experimental rat model.
Erkan YAVUZ ; Onur Olgac KARAGULLE ; Gulcin ERCAN ; Atilla CELIK ; Hakan YIGITBAS ; Busra Yaprak BAYRAK ; Rumeysa TARTAR ; Ramazan KUSASLAN ; Yuksel ALTINEL ; Osman Bilgin GULCICEK
Annals of Surgical Treatment and Research 2018;94(4):174-182
PURPOSE: Radiation proctitis (RP) is inflammation and damage to the rectum, manifested secondary to ionizing radiation utilized for treatment. In this study, we evaluated the anti-inflammatory therapeutical and protective effects of ruscogenin in a model of acute RP. METHODS: Thirty-two Sprague-Dawley rats were divided into 4 groups (n = 8) as sham, control, treatment, and prophylaxis groups. Prophylaxis group and treatment group were dosed ruscogenin by oral gavage for 14 days pre- and postradiation. At the end of the 28th day, all subjects were sacrificed. RESULTS: Histopathological analysis showed a significant increase in cryptitis abscess, cryptitis and reactive atypia, and depth of lymphocytic infiltration of the control group, compared to the other groups (P < 0.05), while treatment and prophylaxis groups showed significant decreases (P < 0.05). Immunohistochemical analysis indicated that immunoreactivity were significantly higher in control group (P < 0.05, P < 0.001, and P < 0.01, respectively), but vice versa for treatment and prophylaxis groups. There was not any significant difference for fibroblast growth factor 2 immunoreactivity. The epithelium of control rectums indicated an increase in TNF-α immunoreactivity while other groups had significant decrease (P < 0.01). Electron microscopical findings were parallel to light microscopy. CONCLUSION: In this study, ruscogenin was observed to be effective on prophylaxis or treatment of acute RP. Although there are various reports on the treatment of the rectum damaged by acute RP in the literature, this could be the first study since there is no research indicating the ultrastructural effect of ruscogenin.
Abscess
;
Animals
;
Epithelium
;
Fibroblast Growth Factor 2
;
Inflammation
;
Microscopy
;
Models, Animal*
;
Proctitis*
;
Radiation, Ionizing
;
Rats*
;
Rats, Sprague-Dawley
;
Rectum
;
Therapeutic Uses*